Evidence for selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of D-amphetamine

Journal of Pharmacology and Experimental Therapeutics

Volumn 277, Issue 2, 1996, Pages 1177-1187

  Bjijou, Y ^a,b   Stinus, L ^a,b   Le Moal, M ^a   Cador, M ^a,b  

^a INSERM   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 5 (4 IODOPHENYL) 3 METHYL 1H 3 BENZAZEPIN 7 OL; DEXAMPHETAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; KETANSERIN TARTRATE; SULPIRIDE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; DRUG ABUSE; DRUG RECEPTOR BINDING; HYPERACTIVITY; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VENTRAL TEGMENTUM;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; AUTORECEPTORS; DEXTROAMPHETAMINE; KETANSERIN; MALE; MORPHINE; MOTOR ACTIVITY; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, GABA-B; RECEPTORS, SEROTONIN; VENTRAL TEGMENTAL AREA;

EID: 0030424441     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. ACKERMAN, J. M. AND WHITE, F. J.: A10 somatodendritic dopamine autoreceptor sensitivity after withdrawal from repeated cocaine treatment. Neurosci. Lett. 117: 181-187, 1990.
2. BISHOFF, S., HEINRICH, M., SONNTAG, J. M. AND KRAUSS, J.: The D-1 dopamine receptor antagonist SCH23390 also interact potently with brain serotonin (5-HT2) receptors. Eur. J. Pharmacol. 129: 367-370, 1986.
3. BONHOMME, N., CADOR, M., STINUS, L., LE MOAL, M. AND SPAMPINATO, U.: Short and long-term changes in dopamine and serotonin receptor binding sites in amphetamine-sensitized rats: A quantitative autoradiographic study. Brain Res. 673: 215-223, 1995.
4. BRUNING, J. L. AND KINTZ, B. L.: Computational Handbook of Statistics, Scott, Foresman and Company, Glenview, II, 1977.
5. CADOR, M , BJIJOU, Y. AND STINUS, L.: Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience 65: 385-395, 1995.
6. CAMERON, D. L. AND WILLIAMS, J. T.: Dopamine D-1 receptors facilitate transmitter release. Nature 366: 344-347, 1993.
7. CARBONI, E., IMPERATO, A., PEREZZANI, L. AND DI CHIARA, G.: Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28: 653-661, 1989.
8. CARLSON, J. H., BERGSTROM, D. A., WEICK, B. G. AND WALTERS, J. R.: Neurophysiological investigation of effects of D-1 agonist SKF38393 on tonic activity of substantia nigra dopamine neurons. Synapse 1: 411-416, 1987.
9. CASTANEDA, E., BECKER, J. B. AND ROBINSON, T E.: The long-term effects of repeated amphetamine treatment in vivo on AMPH, KCl and electrical stimulation evoked striatal dopamine release in vitro. Life Sci. 42: 2447-2456, 1988.
10. DI CHIARA, G.: Searching for the hidden order in chaos. Behav. Pharmacol. 4: 335-337, 1993.
11. DI CHIARA, G AND IMPERATO, A.: Drugs abused by humans preferentially increase synaptic dopamine concentration in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA 85: 5274-5278, 1988.
12. DOUGHERTY, G. G. AND ELLINWOOD, E. H.: Chronic amphetamine in the nucleus accumbens: Lack of tolerance or reverse tolerance of locomotor activity. Life Sci. 28: 2295-2298, 1981.
13. FINK, J. S. AND SMITH, G. P.: Mesolimbocortical dopamine terminal fields are necessary for normal locomotor investigatory exploration in rats. Brain Res. 199: 356-384, 1980.
14. FISHER, J. F. AND CHO, A. K.: Chemical release of dopamine from striatal homogenates: Evidence for an exchange diffusion model. J. Pharmacol. Exp. Ther. 208: 203-209, 1979.
15. GOLDSTEIN, J. M. AND LITWIN, L. C.: Spontaneous activity of A9 and A10 dopamine neurons after acute and chronic administration, of the selective dopamine D-1 receptor antagonist SCH23390. Eur. J. Pharmacol. 155: 175-180, 1988.
16. HENRY, D. J., GREENE, M. A. AND WHITE, F. J.: Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: Repeated administration. J. Pharmacol. Exp. Ther. 245: 1095-1102, 1989.
17. HOOKS, M S., JONES, G. H., SMITH, A. D., NEILL, D. B. AND JUSTICE, J. B.: Response to novelty predicts the locomotor and nucleus accumbens dopamine response to cocaine. Synapse 9: 121-128, 1991.
18. IMPERATO, A., MULAS, A. AND DI CHIARA, G.: The D-1 antagonist SCH 23390 stimulates while the D-1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats. Eur. J. Pharmacol 142: 177-181, 1987.
19. INNIS, R. B. AND AGHAJANIAN, G. K.: Pertussis toxin blocks autoreceptor-mediated inhibition of dopaminergic neurons in rat substantia nigra. Brain Res 411: 139-143, 1987.
20. JEZIORSKI, M., WHITE, F. J. AND WOLF, M. E.: MK-801 prevents the development of behavioral sensitization during repeated morphine administration. Synapse 16: 137-147, 1994.
21. KALIVAS, P. W., WIDERLOV, E., STANLEY, D., BREESE, G. AND PRANGE, A. J.: Enkephalin action on the mesolimbic system: a dopamine dependent and a dopamine independent increase in locomotor activity. J. Pharmacol. Exp. Ther. 227: 229-237, 1983.
22. KALIVAS, P. W. AND ALESDATTER, J. E.: Involvement of N-methyl-D-aspartate receptor stimulation in ventral tegmental area and amygdala in behavioral sensitization to cocaine J. Pharmacol. Exp. Ther. 266: 486-495, 1993.
23. KALIVAS, P. W. AND STEWART, J : Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 223-244, 1991.
24. KALIVAS, P. W. AND WEBER, B.: Amphetamine injection into the A10 dopamine region sensitizes rats to peripheral amphetamine, and cocaine. J. Pharmacol. Exp. Ther. 245: 1095-1102, 1988.
25. KALIVAS, P. W., BOURDELAIS, A., ABHOLD, R. AND ABBOTT, L.: Somatodendritic release of endogenous dopamine: In vivo dialysis in the A10 dopamine region. Neurosci. Lett 100: 215-220, 1989.
26. KALIVAS, P. W., DUFFY, P.: Effect of D-1 receptor stimulation on glutamate and GABA release. Monitoring Molecules in Neurosciences. Proceedings of the 6th International Conference on In Vivo Methods, p. 119, 1994.
27. KARLER, R., CALDER, L. D CHAUDHRY, I. A. AND TURKANIS, S. A.: Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci. 45: 599-606, 1989
28. KARLER, R., CHAUDHRY, I. A., CALDER, L. D. AND TURKANIS, S. A.: Amphetamine behavioral sensitization and the excitatory amino acids. Brain Res. 537: 76-82, 1990.
29. KAMATA, K. AND REBEC, G. V.: Nigra dopaminergic neurons: Differential sensitivity to apomorphine after long-term treatment with low and high doses of amphetamine. Brain Res. 32: 147-150, 1984.
30. KEBABIAN, J. W., AGUI, T., VAN OENE, J. C., SHIGEMATSU K. AND SAAVEDRA, J. M.: The D-1 dopamine receptor: New perspectives. Trends Pharmacol. Sci. 7-96, 1986.
31. KELLEY, A. E., STINUS, L. AND IVERSEN, S. D.: Interactions between D-Ala-Metenkephalin, A10 dopaminergic neurones, and spontaneous behavior in the rats. Behav. Brain Res. 1: 3-24, 1980.
32. KELLY, P. H. AND IVERSEN, S. D.: Selective 6-OHDA destruction of mesolimbic dopamine neurons: Abolition of psychostimulant-induced locomotor activity in rats. Eur. J. Pharmacol. 40: 45-56, 1976.
33. KELLY, P H., SEVIOUR, P. W. AND IVERSEN, S. D.: Amphetamine and apomorphine responses in the rat after 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 94: 507-522, 1975.
34. LACEY, M. G., MERCURI, N. B. AND NORTH, R. A.: Dopamine acts at D-2 receptors to increase potassium conductance in neurons of the rat substantia nigra. J. Physiol. 392: 397-416, 1987.
35. LACEY, M. G., MERCURI, N. B. AND NORTH, R. A.: On the potassium conductance increase activated by GABA-b and dopamine receptors in rat substantia nigra neurons. J. Physiol. 401: 437-454, 1988.
36. MANSOUR, A., MEADOR-WOODRUFF, J. H., BUNZOW, J. R., CIVELLI, O., AKIL, H. AND WATSON, S. J.: Localisation of dopamine D-2 receptor mRNA and D-1 and D-2 binding in the rat brain nd pituitary: An in situ hybridization-receptor autoradiographic analysis. J. Neurosci. 10: 2587-2600, 1990.
37. MEADOR- WOODRUFF, J. H., MANSOUR, A., BUNZOW, J. R., VAN TOL, H. H. M., WATSON, S. J , JR. AND CIVELLI, O.: Distribution of D-2 dopamine receptor mRNA in rat brain. Proc. Natl. Acad. Sci. USA 86: 7625-7628, 1989.
38. NESTLER, E. J., BRUCE, T H. AND WIDNELL, K. L.: Drug addiction: A model for the molecular basis of neural plasticity. Neuron 11: 995-1006, 1993.
39. O'CONNOR, S. E. AND BROWN, R. A.: The pharmacology of sulpiride: A dopamine receptor antagonist. Gen. Pharmacol. 13: 185-192, 1982.
40. OHMORI, T., ABEKAWA, T., MURAKI, A. AND KOYAMA, T.: Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine. Pharmacol. Biochem. Behav. 48: 587-591, 1994.
41. PAULSON, P. E. AND ROBINSON, T. E.: Sensitization to systemic amphetamine, produces an enhanced locomotor response to a subsequent intra-accumbens amphetamine challenge in rats. Psychopharmacology 104: 140-141, 1991.
42. PELLEGRINO, L. J., PELLEGRINO, L J. AND CUSHMAN, A. J.: A Stereotaxic Atlas of the Rat Brain. Plenum Press, New York, 1979.
43. PERUGINI, M. AND VEZINA, P.: Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine. J. Pharmacol. Exp. Ther. 270: 690-696, 1994
44. PIAZZA, P. V., DEMINIERE, J. M., LE MOAL, M. AND SIMON, H.: Factors that predict individual vulnerability to amphetamine self-administration. Science 245: 1511-1513, 1989.
45. RATTERI, M., CERRITO, F., CERVONI, A. M. AND LEVI, G.: Dopamine can be released by two mechanisms differentially affected by the dopamine transport inhibitor nomifensine. J. Pharmacol. Exp. Ther 208: 195-202, 1979.
46. RIDDALL, D. R.: A comparison of the selectivities of SCH23390 with BW737C89 for D-1, D-2 and 5-HT2 binding sites both in vitro and in vivo. Eur. J. Pharmacol 210: 279-284, 1992.
47. ROBINSON, T. E. AND BECKER, J B : Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11: 157-198, 1986.
48. ROBINSON, T. E. AND BERRIDGE, K. C.: The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res. Rev. 18: 247-291, 1993.
49. SATO, M.: A lasting vulnerability to psychosis in patient with previous methamphetamine psychosis. Ann. N.Y. Acad. Sci. 654: 160-170, 1992.
50. SATO, M., CHE, C. C., AKIYAMA, K. M. AND OTSUKI, S.: Acute exacerbation of paranoid psychotic state after long term abstinence in patient with previous methamphetamine psychosis. Biol. Psychiat. 18: 429-440, 1983.
51. 3H]SCH23390 binding sites in pars reticulata and pars compacta of the substantia nigra. Neurosci. lett. 72: 265-271, 1986.
52. SOKOLOFF, P., GIROS, B., MARTRES, M. P., BOUTHENET, M. L. AND SCHWARTZ, J. C.: Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347: 146-151, 1990.
53. STEWART, J. AND DRUHAN, J. P.: Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the noncompetitive NMDA receptor antagonist, MK-S01. Psychopharmacology 110: 125-132, 1993.
54. STEWART, J. AND VEZINA, P.: Microinjections of SCH23390 into the ventral tegmental area and substantia nigra pars reticulata attenuate the development of sensitization to the locomotor activating effects of systemic amphetamine. Brain Res. 495: 401-406, 1989.
55. STINUS, L., KOOB, G. F., LING, N., BLOOM, F. E. AND LE MOAL, M.: Locomotor activation induced by infusion of endorphins into the ventral tegmental area: Evidence for opiate-dopamine interactions. Proc. Natl Acad. Sci. USA 77: 2323-2327, 1980.
56. SVENESON, T. H. AND TUNG, C. S.: Local cooling of prefrontal cortex induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo. Acta Physiol. Scand. 136: 135-136, 1989.
57. 3H] sulpiride to rat striatal preparations. J. Pharmacol. 31: 424-426, 1979.
58. UJIKE, H., ONOUE, R., AKIYAMA, JC, HAMAMURA, T. AND OTSUKI, S.: Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization, Psychopharmacology 98: 89-92, 1989.
59. UJIKE, H., AKIYAMA, K., NISHIDAWA, H., ONOUE, T. AND OTSUKI, S.: Lasting increase in D-1 dopamine receptors in the lateral part of the substantia nigra pars reticulata after subchronic methamphetamine administration. Brain Res., 540: 159-163, 1991.
60. VEZINA, P.: Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat. Brain Res. 605: 332-337, 1993.
61. VEZINA, P., KALIVAS, P. W. AND STEWART, J.: Sensitization occurs to the locomotor effects of morphine and the specific μ opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens. Brain Res. 417: 51-58, 1987.
62. VEZINA, P. AND STEWART, J.: The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res. 499: 108-120, 1989.
63. VEZINA, P. AND STEWART, J.: Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: Lack of conditioned effects. Brain Res. 516: 99-106, 1990.
64. WACHTEL, S. R., HU, X.-T., GALLOWAY, M. P. AND WHITE F. J.: D-1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D-2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Synapse 4: 327-346, 1989.
65. WANG, T. AND FRENCH, E. D.: Electrophysiological evidence for the existence of NMDA and non-NMDA receptors on rat ventral tegmental dopamine neurons. Synapse 13: 270-277, 1993.
66. WHITE, F. J. AND WANG, R. Y.: A10 dopamine neurons: Role of autoreceptors in determining firing rate and sensitivity to dopamine agonists. Life Sci. 34: 1161-1170, 1984.
67. WOLF, M. E., WHITE, F. J., NASSAR, R., BROODERSON, R. J. AND KHANSA, M. R.: Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. J. Pharmacol. Exp. Ther. 264: 249-255, 1993.
68. WOLF, M. E. AND KHANSA, M. R.: repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res. 562: 164-168, 1991.